Page last updated: 2024-08-21

cyclopentane and mk-8776

cyclopentane has been researched along with mk-8776 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kuang, T; Li, JA; Lou, W; Lou, Z; Luo, K; Nowsheen, S; Qin, B; Rong, Y; Song, C; Wang, D; Xu, X; Yuan, J	1

Other Studies

1 other study(ies) available for cyclopentane and mk-8776

Article	Year
Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer. Cell cycle (Georgetown, Tex.), 2018, Volume: 17, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Checkpoint Kinase 1; Cyclopentanes; DNA Damage; DNA Replication; Drug Synergism; Female; G2 Phase Cell Cycle Checkpoints; Humans; Male; Mice, Nude; Middle Aged; Pancreatic Neoplasms; Prognosis; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Ubiquitin-Activating Enzymes	2018

Article

Year

Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer.

Cell cycle (Georgetown, Tex.), 2018, Volume: 17, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Checkpoint Kinase 1; Cyclopentanes; DNA Damage; DNA Replication; Drug Synergism; Female; G2 Phase Cell Cycle Checkpoints; Humans; Male; Mice, Nude; Middle Aged; Pancreatic Neoplasms; Prognosis; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Ubiquitin-Activating Enzymes

2018